Logo

People in the News: Christopher McGuigan, Gary Jacob, Thomas Adams, John Brancaccio, Antonius Schuh, Stanley Tennant

Aug 08, 2013
Premium

Trovagene's stockholders have approved all six of the nominees for its board of directors, all of whom are current directors, to serve until the 2014 annual stockholder meeting. These directors include Christopher McGuigan; Gary Jacob; Thomas Adams; John Brancaccio; Antonius Schuh; and Stanley Tennant.

Filed under

Diagnostics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.